Cargando…

mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancer

Small cell lung cancer (SCLC) is a recalcitrant malignancy with limited treatment options. Bromodomain and extraterminal domain inhibitors (BETis) have shown promising preclinical activity in SCLC, but the broad sensitivity spectrum limits their clinical prospects. Here, we performed unbiased high-t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumari, Anju, Gesumaria, Lisa, Liu, Yan-Jin, Hughitt, V. Keith, Zhang, Xiaohu, Ceribelli, Michele, Wilson, Kelli M., Klumpp-Thomas, Carleen, Chen, Lu, McKnight, Crystal, Itkin, Zina, Thomas, Craig J., Mock, Beverly A., Schrump, David S., Chen, Haobin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077471/ https://www.ncbi.nlm.nih.gov/pubmed/36883564 http://dx.doi.org/10.1172/jci.insight.156657

Ejemplares similares

ATRT-11. DEVELOPMENT OF NOVEL PRECLINICAL MODELS AND THERAPEUTIC STRATEGIES FOR ETMR
por: Cocito, Carolina, et al.
Publicado: (2023)

Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma
por: Wu, Jerry T., et al.
Publicado: (2023)

TRLS-04. PRECLINICAL VALIDATION OF A NOVEL THERAPEUTIC STRATEGY FOR CHOROID PLEXUS CARCINOMA
por: Martin, Brice, et al.
Publicado: (2023)

BETting on combination to overcome PARPi resistance
por: Zhang, Youyou, et al.
Publicado: (2017)

mQC: A Heuristic Quality-Control Metric for High-Throughput Drug Combination Screening
por: Chen, Lu, et al.
Publicado: (2016)

High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma
por: Lang, Martin, et al.
Publicado: (2023)

A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry
por: Xu, Miao, et al.
Publicado: (2021)

A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry
por: Xu, Miao, et al.
Publicado: (2022)

rSK1 in Rat Neurons: A Controller of Membrane rSK2?
por: Autuori, Eleonora, et al.
Publicado: (2019)

A Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19
por: Shrimp, Jonathan H., et al.
Publicado: (2022)

Inhibition of RSK with the novel small-molecule inhibitor LJI308 overcomes chemoresistance by eliminating cancer stem cells
por: Davies, Alastair H., et al.
Publicado: (2015)

RSK1 and RSK2 serine/threonine kinases regulate different transcription programs in cancer
por: Yang, Won Seok, et al.
Publicado: (2023)

A landscape of response to drug combinations in non-small cell lung cancer
por: Nair, Nishanth Ulhas, et al.
Publicado: (2023)

RSK Isoforms in Acute Myeloid Leukemia
por: Youn, Minyoung, et al.
Publicado: (2021)

The ribosomal S6 kinase 2 (RSK2)–SPRED2 complex regulates the phosphorylation of RSK substrates and MAPK signaling
por: Lopez, Jocelyne, et al.
Publicado: (2023)

RSK2 Is a Modulator of Craniofacial Development
por: Laugel-Haushalter, Virginie, et al.
Publicado: (2014)

RSK-c-Fos in KSHV lytic progression
por: Li, Xiaojuan, et al.
Publicado: (2015)

Identifying requirements for RSK2 specific inhibitors
por: Wright, Eric B., et al.
Publicado: (2021)

RSK2 Maintains Adult Estrogen Homeostasis by Inhibiting ERK1/2-Mediated Degradation of Estrogen Receptor Alpha
por: Ludwik, Katarzyna A., et al.
Publicado: (2020)

Animal Models for Coffin-Lowry Syndrome: RSK2 and Nervous System Dysfunction
por: Fischer, Matthias, et al.
Publicado: (2018)

To Bet or Not to Bet on T-bet As a Therapeutic Target in Emphysema?
por: Wang, Xiaoyun, et al.
Publicado: (2019)

Enhanced JunD/RSK3 signalling due to loss of BRD4/FOXD3/miR-548d-3p axis determines BET inhibition resistance
por: Tai, Fang, et al.
Publicado: (2020)

Recruitment and Activation of RSK2 by HIV-1 Tat
por: Hetzer, Claudia, et al.
Publicado: (2007)

RSK1 activation promotes invasion in nodular melanoma
por: Salhi, Amel, et al.
Publicado: (2015)

Role of p90RSK in Kidney and Other Diseases
por: Lin, Ling, et al.
Publicado: (2019)

Effect of RSK4 on biological characteristics of colorectal cancer
por: Ye, Qingqing, et al.
Publicado: (2018)

Effect of RSK4 on Biological Characteristics of Gastric Cancer
por: Hu, Cong, et al.
Publicado: (2020)

RSK1 SUMOylation is required for KSHV lytic replication
por: Liu, Zhenshan, et al.
Publicado: (2021)

ERK1/2-RSK regulation of oestrogen homeostasis
por: Wright, Eric B., et al.
Publicado: (2023)

Publisher Correction: Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma
por: Yang, Yandan, et al.
Publicado: (2022)

Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma
por: Yang, Yandan, et al.
Publicado: (2022)

MEK inhibitors overcome resistance to BET inhibition across a number of solid and hematologic cancers
por: Wyce, Anastasia, et al.
Publicado: (2018)

T-bet-mediated differentiation of the activated CD8(+) T cell
por: Yeo, Crystal J J, et al.
Publicado: (2011)

RSK2 and ERα comrades-in-arms in homeostasis and transformation
por: Ludwik, Katarzyna A., et al.
Publicado: (2020)

Radiation therapy induces immunosenescence mediated by p90RSK
por: Imanishi, Masaki, et al.
Publicado: (2022)

Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay
por: Hanson, Quinlin M., et al.
Publicado: (2020)

Targeting ACE2–RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity Assay
por: Hanson, Quinlin M., et al.
Publicado: (2020)

A single nucleotide polymorphism in the Plasmodium falciparum atg18 gene associates with artemisinin resistance and confers enhanced parasite survival under nutrient deprivation
por: Breglio, Kimberly F., et al.
Publicado: (2018)

Mouse tumor susceptibility genes identify drug combinations for multiple myeloma
por: Zhang, Shuling, et al.
Publicado: (2020)

Drosophila RSK Influences the Pace of the Circadian Clock by Negative Regulation of Protein Kinase Shaggy Activity
por: Beck, Katherina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8o040eroos5jn34pkjsiosi2g2